Related Experiment Video
Updated: Mar 27, 2026
10:10
Experimental Infection with Listeria monocytogenes as a Model for Studying Host Interferon-γ Responses
Published on: November 16, 2016
14.4K
The biology behind interleukin-6 targeted interventions
Xiao Liu1, Gareth W Jones, Ernest H Choy
1Division of Infection and Immunity, The School of Medicine, Cardiff University, Heath Campus, Cardiff , Wales, UK.
Current Opinion in Rheumatology
|January 12, 2016
Summary
Interleukin-6 (IL-6) targeted therapies show promise for chronic diseases and cancer. Understanding IL-6 biology is key to effectively applying these novel biologic drugs in clinical practice.
Area of Science:
- Immunology
- Molecular Biology
- Pharmacology
Background:
- Interleukin-6 (IL-6) is a key inflammatory cytokine involved in immunity and tissue homeostasis.
- Biological drugs targeting IL-6 are emerging as potential treatments for chronic diseases and cancer.
- The complex signaling pathways of IL-6 necessitate a thorough understanding for effective therapeutic application.
Purpose of the Study:
- To review the fundamental biology of IL-6.
- To contextualize IL-6 biology for the development of targeted therapies.
- To explore mechanisms relevant to IL-6 targeted interventions.
Main Methods:
- Review of existing literature on IL-6 biology and targeted therapies.
- Analysis of IL-6 signaling pathways and their complexity.
- Examination of current and emerging IL-6 inhibitory strategies.
Main Results:
- Clinical blockade of IL-6 with tocilizumab has increased interest in IL-6 biology.
- IL-6 influences both innate and adaptive immunity and tissue homeostasis.
- Multiple IL-6-directed interventions are advancing, but optimal application remains under investigation.
Conclusions:
- Inhibitors of IL-6 bioactivity are progressing towards clinical use.
- Understanding IL-6's role in health and disease is crucial for optimizing therapeutic strategies.
- This review provides insights into IL-6 mechanisms and therapeutic approaches.
More Related Videos
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
20
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
20
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
01:24T Cell Types and Functions
3.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
01:20The JAK-STAT Signaling Pathway
13.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.8K
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
738
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
738